Year All202520242023 Oct 31, 2025 Mallinckrodt to Present Data on Terlipressin at the 2025 American Association for the Study of Liver Diseases (AASLD) Annual Meeting Read More Oct 30, 2025 Mallinckrodt to Present Data on Terlipressin in Patients with Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI) at Kidney Week 2025 Read More Oct 15, 2025 Endo Announces Peyronie's Disease Presentation at the North Central Section of the American Urological Association Read More Oct 14, 2025 Mallinckrodt Recognizes First Hepatorenal Syndrome (HRS) Awareness Day Read More Oct 09, 2025 Endo Announces Nine New and Modified Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting Read More Sep 18, 2025 Mallinckrodt Announces Publication of Findings on Treatment Patterns and Outcomes in Patients with Two Types of Arthritis Treated with Acthar® Gel (repository corticotropin injection) Read More Sep 02, 2025 First National Hand Health Month Empowers People to Live a Hands-On Life Read More Aug 12, 2025 "Prime Time," a Branded Peyronie's Disease Commercial for XIAFLEX® (collagenase clostridium histolyticum) Read More Jun 18, 2025 Mallinckrodt Announces Publication of Real-World Insights on Patient Experience with Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector Read More Jun 02, 2025 Endo Champions Men's Health Month with Education, Awareness, and Outreach Read More
Oct 31, 2025 Mallinckrodt to Present Data on Terlipressin at the 2025 American Association for the Study of Liver Diseases (AASLD) Annual Meeting Read More
Oct 30, 2025 Mallinckrodt to Present Data on Terlipressin in Patients with Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI) at Kidney Week 2025 Read More
Oct 15, 2025 Endo Announces Peyronie's Disease Presentation at the North Central Section of the American Urological Association Read More
Oct 09, 2025 Endo Announces Nine New and Modified Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting Read More
Sep 18, 2025 Mallinckrodt Announces Publication of Findings on Treatment Patterns and Outcomes in Patients with Two Types of Arthritis Treated with Acthar® Gel (repository corticotropin injection) Read More
Aug 12, 2025 "Prime Time," a Branded Peyronie's Disease Commercial for XIAFLEX® (collagenase clostridium histolyticum) Read More
Jun 18, 2025 Mallinckrodt Announces Publication of Real-World Insights on Patient Experience with Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector Read More
